We are live on ! Find out more
CTNM

Contineum Therapeutics
CTNM

70 hedge funds and large institutions have $55.4M invested in Contineum Therapeutics in 2025 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 12 increasing their positions, 22 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

35% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 20

11% more funds holding

Funds holding: 63 → 70 (+7)

7.36% less ownership

Funds ownership: 79.89% → 72.53% (-7.4%)

20% less funds holding in top 10

Funds holding in top 10: 5 → 4 (-1)

45% less repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 22

48% less capital invested

Capital invested by funds: $107M → $55.4M (-$51.3M)

Holders
70
Holders Change
+7
Holders Change %
+11.11%
% of All Funds
0.92%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.05%
New
27
Increased
12
Reduced
22
Closed
20
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
+$1.69M
2
Millennium Management
Millennium Management
New York
+$575K
3
Franklin Resources
Franklin Resources
California
+$533K
4
MAM
Monaco Asset Management
Monaco
+$326K
5
Two Sigma Investments
Two Sigma Investments
New York
+$265K

Top Sellers

Rank Fund Capital Flow
1
PA
Perceptive Advisors
New York
-$3.22M
2
BlackRock
BlackRock
New York
-$1.96M
3
VVM
Versant Venture Management
California
-$1.63M
4
SVCM
Saturn V Capital Management
Texas
-$1.05M
5
Geode Capital Management
Geode Capital Management
Massachusetts
-$529K
Name Holding Trade Value Shares
Change 		Change in
Stake
N
76
Nuveen
North Carolina
– -$92.9K -13,307 Closed
RhumbLine Advisers
77
RhumbLine Advisers
Massachusetts
– -$52.9K -7,573 Closed
Mirae Asset Global ETFs Holdings
78
Mirae Asset Global ETFs Holdings
Hong Kong
– -$42.5K -6,094 Closed
CF
79
Corebridge Financial
Texas
– -$35.9K -5,139 Closed
SO
80
STRS Ohio
Ohio
– -$27.2K -3,900 Closed
Legal & General Group
81
Legal & General Group
United Kingdom
– -$25.3K -3,631 Closed
PFSRSONJ
82
Police & Firemen's Retirement System of New Jersey
New Jersey
– -$9.74K -1,396 Closed
California State Teachers Retirement System (CalSTRS)
83
California State Teachers Retirement System (CalSTRS)
California
– -$5.46K -783 Closed
AIP
84
Ameritas Investment Partners
Nebraska
– -$4.75K -680 Closed
New York State Common Retirement Fund
85
New York State Common Retirement Fund
New York
– -$4.19K -600 Closed
AB
86
Amalgamated Bank
New York
– -$3K -362 Closed
Russell Investments Group
87
Russell Investments Group
United Kingdom
– -$2.22K -318 Closed
SCM
88
Sterling Capital Management
North Carolina
– -$544 -78 Closed
BIG
89
Brooklyn Investment Group
New York
– -$468 -67 Closed
PWMG
90
Private Wealth Management Group
New Jersey
– -$301 -43 Closed
1 2 3
4

CTNM Hedge Fund Activity: Q2 2025 in Review

70 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in Contineum Therapeutics (CTNM) for Q2 2025, worth a combined $55.4M — down 48% from $107M a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new CTNM positions and 20 closed out — a net gain of 7 holders — while 12 added to existing stakes and 22 trimmed.

The largest buyer was Point72 Asset Management, opening a new position worth an estimated $1.69M. The largest seller was Perceptive Advisors, cutting an estimated $3.22M.

  • 70 institutional investors held Contineum Therapeutics (CTNM) as of Q2 2025, up from 63 in Q1 2025.
  • Funds reported $55.4M of Contineum Therapeutics stock for Q2 2025, down 48% quarter-over-quarter.
  • 27 funds opened new Contineum Therapeutics positions in Q2 2025 and 20 closed out, a net change of +7 holders.
  • The largest Contineum Therapeutics buyer in Q2 2025 was Point72 Asset Management, an estimated $1.69M added.
  • The largest Contineum Therapeutics seller in Q2 2025 was Perceptive Advisors, an estimated $3.22M sold.

Based on aggregated 13F filings for Q2 2025.